Stock MTEM MOLECULAR TEMPLATES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Molecular Templates, Inc.

Equities

MTEM

US6085502085

Real-time Estimate Cboe BZX
Other stock markets
 01:39:39 2024-05-22 pm EDT 		5-day change 1st Jan Change
1.35 USD -0.74% Intraday chart for Molecular Templates, Inc. -8.28% -64.34%
May. 15 Earnings Flash (MTEM) MOLECULAR TEMPLATES Posts Q1 Revenue $11.1M MT
Apr. 12 Molecular Templates, Inc. Announces Cessation of Maurizio Voi as Chief Medical Officer, Effective April 30, 2024 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Barclays Adjusts Price Target on Molecular Templates to $1 From $4.50, Maintains Overweight Rating
MT
Stifel Nicolaus Adjusts Molecular Templates Price Target to $5 From $9, Maintains Buy Rating
MT
BofA Securities Downgrades Molecular Templates to Underperform From Buy, Sets Price Target at $1.50
MT
Stifel Adjusts Molecular Templates' Price Target to $9 From $11, Reiterates Buy Rating
MT
Barclays Adjusts Molecular Templates' Price Target to $4.50 from $8, Keeps Overweight Rating
MT
Oppenheimer Lowers Price Target for Molecular Templates to $9 From $13, Maintains Outperform Rating
MT
MOLECULAR TEMPLATES : UBS Adjusts PT on Molecular Templates to $8 From $13 on MT-3724 Discontinuation, TAK-169 Rights Reversion, MT-6402 Program Start; Neutral Rating Kept
MT
MOLECULAR TEMPLATES : BofA Securities Starts Molecular Templates at Buy with $12 Price Target
MT
MOLECULAR TEMPLATES : Oppenheimer Adjusts Molecular Templates' Price Target to $13 From $18, Maintains Outperform Rating
MT
MOLECULAR TEMPLATES : UBS Starts Molecular Templates at Neutral With $13 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MTEM Stock
  4. News Molecular Templates, Inc.
  5. Analyst Reco.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW